United Therapeutics | UTHR - El Costo De Ventas





El Costo De Ventas Cambio Fecha
Amarin USD 26.05M 1.41M 2025-12
Ardelyx USD 10.85M 6.87M 2025-12
Baxter International USD 1.81B 587M 2026-03
Bayer EUR 5.23B 731M 2026-03
BioCryst Pharmaceuticals USD 9.52M 7.34M 2025-12
Biogen USD 797.5M 302M 2026-03
BioMarin Pharmaceutical USD 199.48M 37.93M 2026-03
Emergent BioSolutions USD 381.2M 226.1M 2023-06
Esperion Therapeutics USD 27.85M 13.43M 2025-12
Gilead Sciences USD 1.44B 174M 2026-03
GlaxoSmithKline GBP 1.88B 736M 2026-03
Halozyme Therapeutics USD 108.75M 6.6M 2026-03
Insmed USD 49.5M 3.34M 2026-03
Ionis Pharmaceuticals USD 3M 5M 2026-03
J&J USD 8.07B 103M 2026-03
Lexicon Pharmaceuticals USD 201K 191K 2025-12
Moderna USD 955M 503M 2026-03
Omeros USD 33.16M 18.52M 2024-06
Pfizer USD 4.59B 1.7B 2026-03
PTC Therapeutics USD 39.61M 23.31M 2026-03
Regeneron Pharmaceuticals USD 669.4M 84.8M 2026-03
Sangamo BioSciences 2.42M 1.11M 2024-06
Sarepta Therapeutics USD 109.46M 289.93M 2026-03
Teva Pharmaceutical Industries USD 2.01B 46M 2026-03
United Therapeutics USD 133.4M 341.3M 2026-03
Vertex Pharmaceuticals USD 392.8M 73.2M 2026-03